Mitochondrial DNA haplogroups may influence Fabry disease phenotype

Area of Science:

• Genetics
• Mitochondrial Biology
• Rare Diseases

Background:

• Fabry disease (FD) exhibits significant clinical heterogeneity, even within families.
• Mitochondrial dysfunction and oxidative stress are increasingly recognized in FD pathogenesis.

Purpose of the Study:

• To investigate the potential role of mitochondrial DNA (mtDNA) genetic polymorphisms in Fabry disease clinical expression.
• To determine if specific European mtDNA haplogroups are associated with susceptibility to Fabry disease in an Italian cohort.

Main Methods:

• Genotyping of European mtDNA haplogroups was performed in 77 Italian Fabry disease patients and 151 healthy controls.
• Statistical analysis was used to compare haplogroup frequencies between patients and controls.

Main Results:

• Haplogroups H and I, and the HV haplogroup cluster, were found to be significantly more frequent in Fabry disease patients compared to controls.
• No significant correlation was observed between these mtDNA haplogroups and factors like gender, age of onset, or organ involvement.

Conclusions:

• Mitochondrial genetic variation, specifically certain European mtDNA haplogroups, may contribute to the susceptibility and pathogenesis of Fabry disease in the Italian population.
• Further research is warranted to elucidate the precise mechanisms by which mtDNA variations influence Fabry disease presentation.